Autumn 2018 BioVolume Events
Come visit Fuel3D and check out BioVolume in these events during Autumn 2018.
BioVolume® from Fuel3D is the world’s first 3D imaging solution that has been developed in partnership with the pharmaceutical industry for measuring subcutaneous tumour growth in pre-clinical oncology research. This ground-breaking platform rapidly and accurately captures and reconstructs 3D tumour surface changes, enabling the analysis of texture, colour, shape and volume. It disrupts the industry’s approach to pre-clinical oncology research by improving the traceability, accuracy and reproducibility of data and animal welfare. BioVolume is a step forward for cancer research with its potential to reduce the cost and length of pre-clinical trials by improving transparency and veracity in the collection and storage of trial data to increase the speed of drugs to market.
Come visit us on the stand or attend these presentations to discover further benefits of BioVolume:
AALAS (Booth #920)
- Sunday 28th October: Using 3D Scanning to Standardise the Measurement of Subcutaneous Tumours (Andrew Smith, 2:40 PM, Room 343)
- Tuesday 30th October – Platform Session: Using 3D Measurement and Machine Learning to Quantify Subcutaneous Tumours and Improve Animal Welfare and the 3rs in Cancer Research (Dr. Juan Delgado, 4:15 PM, Room 316)
NCRI (Booth #43)
- Tuesday 6th of November: Using 3D Scanning to Standardise the Measurement of Subcutaneous Tumours (Dr. Juan Delgado & Andrew Smith, 8AM)
- Tuesday 27th of November: Computer-Aided Detection and Measurement of Subcutaneous Tumours in Mice (Dr. Jamshid Dehmeshki, 4PM)
To pre-book a meeting at any of the above events, please write to Laura Pastor